In nasopharyngeal carcinomas, EBV-specific IgA serum antibodies, specially, EA and VCA IgA, were suggested to be able to identify individuals at early stage of the disease and also potential predictors of disease prognosis.69,70 We identified only 4 studies comparing EBV seropositivity between gastric cancer patients and healthy controls, all of which were conducted among all Eastern Asians or Eastern Asian descendants. Here, CD79A is linked to nasopharyngeal carcinoma.